Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/5860
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSayfutdinova Zuhra Abdurashid qizi-
dc.date.accessioned2023-01-19T06:37:39Z-
dc.date.available2023-01-19T06:37:39Z-
dc.date.issued2021-
dc.identifier.issn2181-781-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/5860-
dc.description.abstractGipoksiyani keltirib chiqaradigan omil (HIF) -1 organizmning past kislorod konsentratsiyasi yoki gipoksiya holatiga ta’sirida muhim rol o’ynaydigan dimerik oqsil kompleksidir. HIF-1 gomeostatik jarayonda ishtirok etadigan asosiy genlardan biridir, bu mahalliy ishemiya va o’smalar kabi gipoksik sohalarda qon tomirlanishini kuchaytirishi mumkin. Bu o’nlab maqsadli genlar uchun transkripsiya omilidir; HIF-1 immunologik reaktsiyalar uchun ham muhimdir va gomeostaz, vaskulyarizatsiya va anaerob metabolizmning muhim fiziologik regulyatori hisoblanadi. Bundan tashqari, HIF-1 terapevtik potentsiali tufayli tobora ko’proq o’rganilmoqda. Anjiyogenezni keltirib chiqarganligi sababli, ishemik bemorlarda ushbu genning regulyatsiyasi kislorod bilan ta’minlash uchun zarur bo’lgan qon tomirlarining ko’payishiga yordam berishi mumkin. Tadqiqotda HIF-1 yo’lining saraton va ishemiya kabi kasalliklarni davolash uchun terapevtik aralashuv sifatida potentsiali o’rganiladi.en_US
dc.language.isootheren_US
dc.publisherToshkent tibbiyot akademiyasi axborotnomasi,33-36ben_US
dc.relation.ispartofseriesУДК;616.005.4:616-092:612.014.1:616.152.21-
dc.subjectgipoksiya, ishemiya, gipoksiya keltirib chiqaradigan omil, gomeostaz, anaerob glikoliz, Krebs sikli.en_US
dc.titleGipoksiyani keltirib chiqaradigan omil-1 (HIF-1) ning zamonaviy tushunchalari ishemik to’qima shikastlanishining patogenezidagi muhim bo’g’in sifatidaen_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
№20. Sayfutdinova Z.A. вестн3. 2021_removed.pdf828.1 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.